Zorica Lepšanović

Zorica Lepšanović

Auto-generated profile, based on publicly available information

Zorica Lepšanović

Affiliations Military Medical Academy, Belgrade, Serbia, Medical Faculty, University of Defence, Belgrade, Serbia

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2013 in Antonie van Leeuwenhoek
Verified
Journal Article
Closed access
PDF file
BJBranko Jovcic
Branko Jovcic
ZLZorica Lepšanović
Zorica Lepšanović
JBJelena Begović
Jelena Begović
BFBrankica Filipić
Brankica Filipić
MKMilan Kojić
Milan Kojić

8 September 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BRBojan Rakonjac
Bojan Rakonjac
ZLZorica Lepšanović
Zorica Lepšanović
Vesna ŠuljagićVesna Šuljagić
Vesna Šuljagić
BJBranko Jovčić
Branko Jovčić
MKMilan Kojić
Milan Kojić
IĆIvana Ćirković
Ivana Ćirković
Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) is continually changing. Frequency of genotypes typical for community-associated MRSA (CA-MRSA) is increasing in hospitals, as well as resistance to antimicrobial agents. Moreover, different clones predominate in different geographic regions, and temporal shifts occur in the predominant clonal type. The aim of this study was to estimate the prevalence of MRSA, CA-MRSA and PVL-positive MRSA isolates from patients hospitalised in the Military Medical Academy (MMA) and from outpatients, and to perform genotyping of PVL-positive MRSA isolates. MRSA isolates were obtained by standard microbiological techniques. PVL-positive MRSA were detected by single PCR. Determination of SCCmec types in MRSA isolates was done using multiplex PCR and genotyping of PVL-positive MRSA by PFGE, MLST and spa typing. The prevalence of MRSA among S. aureus isolates from different clinical specimens was 43.4%. In outpatients the prevalence of MRSA was 3.2%. SCCmec types specific for CA-MRSA were found in 26% of MRSA isolates from hospitalised patients. In groups, hospitalised patients and outpatients, the prevalence of PVL-positive MRSA isolates was 4%, and all of them harboured SCCmec type V genetic element. PFGE revealed minor differences between four groups of PVL-positive MRSA isolates, but all of them belonged to ST152, and all except one were of the t355 spa type. High prevalence of MRSA and CA-MRSA in MMA, especially the presence of PVL-positive CA-MRSA, represent a serious health threat for patients. Genotype t355/ST152/SCCmec V is the dominant MRSA clone among PVL-positive CA-MRSA.

6 April 2018 in Journal of Food Safety
Verified
Journal Article
Closed access
PDF file
ZLZorica Lepsanovic
Zorica Lepsanovic
VDVesna Djordjevic
Vesna Djordjevic
BLBrankica Lakicevic
Brankica Lakicevic
DSDejana Savic
Dejana Savic
Branko VelebitBranko Velebit
Branko Velebit
NKNedjeljko Karabasil
Nedjeljko Karabasil

1 January 2003 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
MCMiloje Cobeljic
Miloje Cobeljic
IBIvanko Bojic
Ivanko Bojic
DODolores Opacic
Dolores Opacic
ZLZorica Lepsanovic
Zorica Lepsanovic
SLSrdjan Lazic
Srdjan Lazic
A ?new? group of pathogenic agents, enterohemorrhagic Escherichia coli (EHEC) (particularly the strains of O157 serogroup), emerged in the last 20 years causing an increased number of sporadic and epidemic diarrhoeal diseases with hemorrhagic enterocolitis as a most common clinical manifestation of the infection. As a consequence of the absorption and cytotoxic effect of the main virulence factor of these bacteria - verotoxin (shiga-toxin), in about 10% of the affected persons extraintestinal complications, most frequently hemolytic-uremic syndrome (HUS), occurred 7-14 days after an episode of diarrhoeal disease. The first case of hemorrhagic enterocolitis with the documented EHEC O157 infection in Yugoslavia is presented in this paper. Considering the existing expansion trend of these carriers, practitioners should be aware of them in case of the occurrence of diarrhoeal disease (particularly hemorrhagic enterocolitis), and keep these patients under control during the reconvalescence period because of potential development of extraintestinal complications, such as HUS.

1 January 2019 in Ratarstvo i povrtarstvo
Verified
Journal Article
Open access
PDF file
DPDobrivoj Živorad Poštić
Dobrivoj Živorad Poštić
DJDragana Jošić
Dragana Jošić
ZLZorica Lepšanović
Zorica Lepšanović
GAGoran Aleksić
Goran Aleksić
DLDragana Latković
Dragana Latković
MSMira Sava Starovic
Mira Sava Starovic
This study assesses the potential of antibiotics-producing Pseudomonas chlororaphis strains to increase potato yield and to inhibit the mycelial growth of phytopathogenic fungi Fusarium oxysporum (Fo) isolated from potato. P. chlororaphis subsp. aurantiaca strain Q16 (PchlQ16) caused the highest growth inhibition (67.07%) of FoA2 isolate in vitro. In field trials the effect of PchlQ16 was measured as the number of stems, number and weight of tubers and a total potato yield of the Rudolph potato variety. Application of P. chlororaphis and the number of treatments exhibited a significant effect on the yield. Two treatments of PchlQ16 increased the total yield of tubers from 4.9% to 33.05%, while four treatments from 9.3% to 92.35%, compared to the control. Based on our field results we can recommend a frequent application of PchlQ16 (4 times) during potato growth season. The results of our in vitro experiment support these findings as the bacterial strain suppressed growth of F. oxysporum. In this investigation PchlQ16 was confirmed as an effective growth promoting agent in potato production and can be highly effective in prevention of F. oxysporum infection.

1 January 2011 in SCRIPTA MEDICA
Verified
Journal Article
Open access
PDF file
VMVeljko Mirović
Veljko Mirović
BCBiljana Carević
Biljana Carević
SSSrđan Stepanović
Srđan Stepanović
ZLZorica Lepšanović
Zorica Lepšanović
Background. We described an emerging outbreak of infection caused by metallo-ß-lactamase (MBL)-producing Proteus mirabilis that occurred in the surgical ICU of a Serbian university hospital, and assessed this outbreak in a retrospective observational study. Methods. Records from patients in this ICU who had MBL-producing P. mirabilis isolates were reviewed retrospectively. All enterobacterial isolates from clinical specimens (one per patient) were tested for MBL production. We used a multiplex PCR assay to detect and differentiate each of the MBL gene families: IPM, VIM, SPM, GIM and SIM. In July and in November 2008, we conducted a point prevalence survey of rectal colonization with MBL-producing P. mirabilis. Results. From June through November, 2008, nine patients in the surgical ICU were infected by MBL-producing P. mirabilis. These isolates exhibited multi-drug resistance. The outbreak was discovered in June and expanded rapidly; ten of twelve (83%) patients in ICU were colonized with outbreak strains in July. Seven cases of bacteremia, including 3 intravascular catheter related, one surgical site infection, and one urinary tract infection were identified. Six of nine MBL-positive P. mirabilis strains belonged to the IPM family, and three others belonged to the VIM family. Actual mortality was 56%, but we could not determine mortality indirectly attributable to the infection. Conclusion. The rapid emergence of MBL-producing P. mirabilis within a Serbian hospital created a challenge for clinicians, microbiologists, and epidemiologists. This resistant infection added further to the established cases of antimicrobial resistance within the hospital.